Azelis Pharma adds excipients to product portfolio


To be sold in UK through S. Black

Azelis, a Pan European distributor of specialist chemicals headquartered in Antwerp, Belgium, is to sell Syral’s starch-derived excipients in the UK through S. Black in Hertford.

The range includes liquid and powder (Directly Compressible (DC)) forms of sorbitol, maltitol in liquid and powder forms (non DC), maize starch, dextrose monohydrate (DC), maltodextrins (DC), dextrose anhydrous and glucose syrup. Meritab, a DC excipient based on a blend of dextrose monohydrate and maltodextrin are also included for the supplements market.

The Syral products are used in several pharmaceutical applications, including capsules, tablets, suspensions and syrups, and most of them meet the European and US Pharma monographs.

‘The addition of Syral’s starch-based derivatives to our portfolio extends the basket of oral excipients we offer to the pharmaceutical market,’ said Trevor Bridger, regional business manager for Azelis Pharma in the UK.

‘These, combined with our speciality flavours, sweeteners and other oral excipients mean that we are well placed to provide a good technical, product and logistics service to producers of tablets, capsules, sachets and liquid medicines.’